Global Autologous Fat Grafting Market, By Product Type (Integrated Fat Transfer Systems, Aspiration and Harvesting Systems, Liposuction Systems, Fat Processing Systems, De-epithelialization Devices, and Accessories), Application (Breast Augmentation, Buttock Augmentation, Facial Fat Grafting, Hand Rejuvenation, and Others), Gender (Male and Female), Age Group (20-40, 41-50, and Above 50), End User (Hospitals, On-Site Clinics, Plastic Surgery Centers, and Others) Distribution Channel (Direct Tender and Retail Sales) - Industry Trends and Forecast to 2030.
Autologous Fat Grafting Market Analysis and Insights
The global autologous fat grafting market is expected to grow in the forecast period due to the increasing demand for minimally invasive procedures and decreased disparity between men and women for aesthetic functions. The market is also influenced by the growing aesthetic consciousness and beauty standards and growing technological advancement. However, the global autologous fat grafting market is expected to be hampered by the high cost of procedures, increased risks associated with the procedures, and high cost of procedures.
The customized treatment plans and integration with other aesthetic procedures, beliefs, and trends of autologous fat grafting in young adults the focus on inclusivity and diversity, and the expansion of product lines are expected to act as opportunities for market growth. However, unfavorable reimbursement scenario and a lack of skilled professional is expected to challenge market growth.
The demand for the autologous fat grafting market has increased in both developed and developing countries, and the reason behind this is its effectiveness and availability. Thus, many market players offer autologous fat grafting products with innovations that pave the way for the growth of the global autologous fat grafting market.
Data Bridge Market Research analyzes that the global autologous fat grafting market is expected to reach a value of USD 2,498,109.12 thousand by 2030, at a CAGR of 9.8% during the forecast period.
Report Metric |
Details |
Forecast Period |
2023 to 2030 |
Base Year |
2022 |
Historic Years |
2021 (Customization from 2015 to 2020) |
Quantitative Units |
Revenue in USD Thousand, Volumes in Units, Pricing in USD |
Segments Covered |
Product Type (Integrated Fat Transfer Systems, Aspiration and Harvesting Systems, Liposuction Systems, Fat Processing Systems, De-epithelialization Devices, and Accessories), Application (Breast Augmentation, Buttock Augmentation, Facial Fat Grafting, Hand Rejuvenation, and Others), Gender (Male and Female), Age Group (20-40, 41-50, and Above 50), End User (Hospitals, On-Site Clinics, Plastic Surgery Centers, and Others) Distribution Channel (Direct Tender and Retail Sales) |
Countries Covered |
U.S., Canada, and Mexico, Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Poland, Sweden, Belgium, Denmark, Finland, Norway, and Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines, New Zealand, Taiwan, Vietnam, and Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Qatar, Oman, Bahrain, Kuwait, and Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America |
Market Players Covered |
AbbVie Inc., Alma Lasers, Tulip Aesthetics, Bimini Health Tech, Aspire Medical Innovation, Sterimedix Limited, and Genesis Biosystems, MTF Biologics, MicroAire Surgical Instruments, LLC, Medicon eG, Human Med AG, Tulip Aesthetics, Lipogems International S.p.A., HK Surgical Inc., MÖLLER Medical GmbH, Grey Medical, Genesis Biosystems, among others. |
Autologous Fat Grafting Market Definition
Autologous fat grafting, also known as autologous fat transfer or lipofilling, is a medical procedure that involves the removal of fat from one part of a person's body, such as the abdomen, thighs, or buttocks, using a gentle liposuction technique. The harvested fat is then processed to purify and prepare it for transplantation. This purified fat is strategically injected into another area of the same person's body, often the face, breasts, hands, or buttocks, to enhance volume, contour, and symmetry.
Autologous Fat Grafting Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
- Increasing demand for minimally invasive procedures
The use of minimally invasive and non–invasive procedures has been shifted as compared to traditional methods for autologous fat grafting techniques including laser and other energy-based devices. For the use of surgical or non-surgical procedures, specially designed instruments have been developed for minimally used procedures.
Minimally invasive surgery is a procedure conducted with the assistance of a scope of viewing and specially equipped surgical instruments. Using minimally invasive procedures allows no cuts or minimal cuts with lesser recovery time allowing the increasing demand and use of minimally invasive procedures. Other reasons for the rise of procedures can be defined by the increasing aging people and the requirement for healthcare facilities including patient-friendly techniques whose medical requirements are maximum, which can further result in a decreased burden on healthcare facilities.
The minimally invasive procedures are in line with the patient's comfort. They almost do not have any side effects and their time of recovery is too low. Therefore, people feel more comfortable getting a procedure done for their aesthetic enhancement. Hence, increased demand for minimally invasive procedures is expected to act as a driver for the market.
- Growing Technological Advancements
Over the past few years, the advancement in the technology of autologous fat grafting devices has potentially helped in enhancing the appearance of consumers. The high-tech autologous fat grafting devices helped in achieving the desired body shape by the patients. The advanced technology-based autologous fat grafting devices aid in the reduction of excess fat from regions such as the buttocks, thigh, arms, face, and abdomen among others.
With the advancement in technology, various techniques are available to perform autologous fat grafting. Current liposuction technology includes suction-assisted, ultrasonic, power-assisted, laser-assisted, and radio frequency-assisted lipectomy. The most advanced liposuction technique is water-assisted liposuction whereas the technologically advanced emerging medical technology for liposuction is RF-assisted liposuction. The Radio-frequency assisted liposuction devices show the most promising result along with a significant amount of international data and expertise
Opportunity
- Belief and Trend of Autologous Fat Grafting in Young Adults
With the belief and escalation of the ‘to look good’ trend in terms of physical appearance in young adults, fat grafting has become popular among adults. External physical appearance is now becoming a vitally important factor that tells about a person's professional and personal status. The relationship between physical appearance and a professional career is not new; even across the world, this belief that a good-looking person must have a high-paying job is old. However, this deeply penetrated belief encouraged many individuals to undergo fat surgery as the medium to meet their social and professional needs. Young adults' acceptance of and preference for the worldwide autologous fat grafting trend have been progressively rising in recent years. Young individuals are more aware of their body image and are looking for non-invasive ways to fix problem areas.
Restraints/Challenges
- High cost of procedures
Modern technology-based autologous fat grafting devices help tone and tighten various body parts by reducing fat using technologically advanced modalities such as ultrasound-based, laser-assisted, or radiofrequency-assisted autologous fat grafting devices. The cost of autologous fat grafting varies significantly from place to place or region to region. The key factors, that determine the cost of autologous fat grafting, include factors such as the medical institution or clinic finalized for the procedure, treatment area, affected area, duration of the stay of the patient, and the complexity of surgery among more. The high cost of the procedure is due to the various checkpoints of the surgery along with the use of high-tech modalities to perform such procedures. As the cost of technologically advanced autologous fat grafting devices is high, the procedure cost proportionally is escalated, due to which the high cost of the procedure is expected to restrain market growth.
Recent Developments
- In August 2023 Bimini Health Tech announced that it had acquired substantially all of the assets of Ideal Implant, Inc., including intellectual property, regulatory approvals, product inventory, and certain manufacturing capacity. This helps the organization develop more revenue.
- In April 2022, Bimini Health Tech (“Bimini” or the “Company”), a diversified global medical aesthetics and regenerative therapy company, announced today that it has received approval from Canada’s Medical Devices Directorate to market the Company’s Dermapose family of microsizing syringe products, including the Dermapose Refresh Microsizing Syringe and the Autopose Restore Microsizing Syringe in Canada. This helps the organization develop more revenue.
- In December 2021, Allergan (a subsidiary of AbbVie Inc.) announced that the company had completed its acquisition with Soliton, Inc. This helped the company expand its aesthetic product portfolio in the market.
- In April 2021, Alma Lasers launched the new Alma PrimeX platform during a global LIVE launch event streamed from its headquarters studio. The best product in its class, Alma PrimeX offers unmatched results in circumference reduction and skin tightening. This aided the business in expanding its product offering.
Market Scope
The global autologous fat grafting market is categorized into six notable segments based on product type, application, gender, age group, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Product Type
- Liposuction Systems
- Aspiration and Harvesting Systems
- Fat Processing Systems
- Integrated Fat Transfer Systems
- De-Epithelialization Devices
- Accessories
On the basis of product type, the market is segmented into liposuction systems, aspiration and harvesting systems, fat processing systems, integrated fat transfer systems, de-epithelialization devices, and accessories.
Application
- Breast Augmentation
- Buttock Augmentation
- Facial Fat Grafting
- Hand Rejuvenation
- Others
On the basis of application, the market is segmented into breast augmentation, buttock augmentation, facial fat grafting, hand rejuvenation, and others.
Gender
- Female
- Male
On the basis of gender, the market is segmented into male and female.
Age Group
- 41-50
- 20-40
- Above 50
On the basis of age group, the market is segmented into 41-50, 20-40, and above 50.
End User
- Hospitals
- Plastic Surgery Centers
- On-Site Clinics
- Others
On the basis of end user, the market is segmented into hospitals, plastic surgery centers, on-site clinics, and others.
Distribution Channel
- Direct Tender
- Retail Sales
On the basis of distribution channel, the market is segmented into direct tenders and retail sales.
Global Autologous Fat Grafting Market Regional Analysis/Insights
The global autologous fat grafting market is analyzed, and market size insights and trends are provided based on product type, application, gender, age group, end user, and distribution channel as referenced above.
The countries covered in this market report U.S., Canada, and Mexico, Germany, France, U.K., Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Poland, Sweden, Belgium, Denmark, Finland, Norway, and Rest of Europe, China, Japan, India, Australia, South Korea, Singapore, Malaysia, Indonesia, Thailand, Philippines, New Zealand, Taiwan, Vietnam, and Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Qatar, Oman, Bahrain, Kuwait, and Rest of Middle East and Africa, Brazil, Argentina, and Rest of South America.
North America is expected to dominate the global autologous fat grafting market in terms of market share and market revenue. The U.S. is expected to dominate the North America region due to the increasing investment in autologous fat grafting and the strong presence of key players. Germany is expected to dominate Europe region due to the increasing demand from emerging markets and expansion. China is expected to dominate the Asia-Pacific region due to the increasing customer inclinations towards advanced technological processes.
The country section of the report also provides individual market-impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, and impact of sales channels are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Autologous Fat Grafting Market Share Analysis
The global autologous fat grafting market competitive landscape provides details of competitors. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product approvals, product width and breadth, application dominance, and product type lifeline curve. The above data points provided are only related to the company’s focus on the global autologous fat grafting market.
Some of the key players operating in the market are AbbVie Inc., Alma Lasers, Tulip Aesthetics, Bimini Health Tech, Aspire Medical Innovation, Sterimedix Limited, and Genesis Biosystems, MTF Biologics, MicroAire Surgical Instruments, LLC, Medicon eG, Human Med AG, Tulip Aesthetics, Lipogems International S.p.A., HK Surgical Inc., MÖLLER Medical GmbH, Grey Medical, Genesis Biosystems, among others.
SKU-